$QCLS 3 SEC Filings

Filed On	Filing
22 Sep 2026	Form 3: Ehrlichman Yossef, Chief Technology Officer No securities owned
17 Aug 2026	Form 3: Fagan Charles Todd, Chief Financial Officer No securities owned
30 Jan 2026	Form 3: Voss Chelsea Sierra, Director Holds 59,802 shares of Common stock
06 Oct 2025	Form 3: Bernstein Bruce, Director Holds 23 shares of Common stock, par value $0.001 per share
28 Jun 2024	Form 3: Friscia Stephen, Director No securities owned
30 May 2024	Form 3: PharmaCyte Biotech, Inc., 10% owner
16 May 2024	Form 3: Glass Mitchell, Director No securities owned
26 Apr 2021	Form 3: Williams Caroline C, 10% owner Holds 1,272,972 shares of Common Stock
22 Apr 2021	Form 3: Eagle Craig, Director No securities owned
21 Apr 2021	Form 3: Kaplin Adam, Chief Scientific Officer No securities owned
21 Apr 2021	Form 3: Uzonwanne Jude, Director No securities owned
21 Apr 2021	Form 3: Chapman Christopher C Jr, Director No securities owned
20 Apr 2021	Form 3: Rivard Paul, EVP of Operations, GC No securities owned
11 Feb 2021	Form 3: Rhodes Ian, Interim CFO No securities owned
31 Aug 2020	Form 3: Benson Stuart M, Chief Financial Officer No securities owned
07 Jan 2020	Form 3: Hudson Bay Capital Management Lp, 10% owner and 1 other Holds 84,665 shares of Common Stock, no par value ("Common Stock")
07 Nov 2019	Form 3: Schroeder Robert C, Director No securities owned
16 Oct 2018	Form 3: Yeaton Howard, CEO, CFO No securities owned
21 Sep 2018	Form 3: Schreiber Christopher C, Director No securities owned
20 Sep 2018	Form 3: Silverman Joshua, Director No securities owned

Comments